CCAB and Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
September 10, 2018 09:00 ET
|
Centre for the Commercialization of Antibodies and Biologics
AUSTIN, Texas and HAMILTON, Ontario and TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc....